Skip to content
Clinical Trials – home

Cholestyramine: A Comprehensive Guide for Patients

1 / 4
trials open to patients / all trials
23+
Countries

In short

This article examines several clinical trials investigating the use of cholestyramine, a bile acid sequestrant, in various medical conditions. Cholestyramine has been studied for its potential benefits in managing hyperthyroidism, nonalcoholic fatty liver disease, and its interactions with other medications. These trials provide valuable insights into the drug's efficacy, safety, and potential applications in different therapeutic areas.

At a glance

Primary Uses
Lowering cholesterol, adjunctive therapy in hyperthyroidism, potential treatment for NAFLD
Mechanism of Action
Binds to bile acids in intestine, prevents reabsorption, increases excretion of bound substances
Dosage Forms
Powder, typically mixed with liquid before administration
Dosage Range
1-12 grams per day, depending on the condition and study protocol
Combination Therapies
Studied with metformin, elobixibat, and standard hyperthyroidism treatments
Patient Considerations
Taste and texture may affect acceptability; BASA scale used to assess patient experience
Potential Benefits
Rapid reduction of thyroid hormone levels, improved lipid profiles, potential liver fat reduction
Areas of Research
Drug interactions, efficacy in various conditions, optimal dosing strategies

What is Cholestyramine?

Cholestyramine is a medication that belongs to a class of drugs called bile acid sequestrants. It is also known by the brand name Questran. Cholestyramine comes in a powder form that is mixed with liquid and taken orally.

Medical Conditions Treated

Cholestyramine is used to treat various medical conditions, including:

  • Hyperthyroidism: An overactive thyroid gland that produces too much thyroid hormone.
  • Graves' Disease: An autoimmune disorder that causes hyperthyroidism.
  • Nonalcoholic Fatty Liver Disease (NAFLD): A condition where excess fat accumulates in the liver of people who drink little or no alcohol.
  • Nonalcoholic Steatohepatitis (NASH): A more severe form of NAFLD that includes liver inflammation and damage.

How Cholestyramine Works

Cholestyramine works by binding to bile acids in the intestine and increasing their excretion in the feces. This mechanism has several effects:

  • Lowering cholesterol: By removing bile acids, the body is forced to use cholesterol to make more, which can lower blood cholesterol levels.
  • Reducing thyroid hormone levels: In hyperthyroidism, cholestyramine can help decrease the enterohepatic circulation (recycling) of thyroid hormones, leading to their increased excretion.
  • Altering bile acid pool: This can affect various metabolic processes in the body.

Dosage and Administration

The dosage of cholestyramine can vary depending on the condition being treated and the individual patient. Some common dosages used in clinical trials include:

  • 1 gram twice daily
  • 2 grams twice daily
  • 4 grams twice to four times daily
  • 9 grams (containing 4 grams of cholestyramine) once daily

Cholestyramine is typically mixed with water or another liquid before consumption. The exact mixing instructions may vary, so it's important to follow your healthcare provider's directions carefully.

Combination Therapies

Cholestyramine is often used in combination with other medications to enhance its effectiveness or to treat multiple aspects of a condition. Some combination therapies include:

  • Cholestyramine with methimazole and propranolol: This combination is used in the treatment of hyperthyroidism.
  • Cholestyramine with elobixibat: This combination is being studied for the treatment of nonalcoholic fatty liver disease.
  • Cholestyramine with metformin: This combination is being investigated for its effects on blood glucose levels and gut microbiome.

Side Effects and Tolerability

While cholestyramine is generally considered safe, it can have some side effects. The tolerability of the medication can vary among patients. Some studies have specifically looked at patient acceptability of cholestyramine, considering factors such as:

  • Taste
  • Texture
  • Appearance
  • Mixability

These factors can affect how well patients adhere to their prescribed treatment regimen. If you experience any discomfort or side effects while taking cholestyramine, it's important to discuss these with your healthcare provider.

Ongoing Research

Cholestyramine continues to be the subject of ongoing research to explore its potential benefits in various conditions. Some areas of current investigation include:

  • Effects on bile acid pool: Researchers are studying how changes in bile acid levels caused by cholestyramine might affect the body's response to other medications, such as metformin.
  • Impact on gut microbiome: There is interest in understanding how cholestyramine might alter the composition of bacteria in the intestines.
  • Combination therapies for liver diseases: Studies are exploring the potential benefits of combining cholestyramine with other medications for treating conditions like nonalcoholic fatty liver disease.

As research continues, our understanding of cholestyramine's benefits and optimal use may evolve. Always consult with your healthcare provider for the most up-to-date information about this medication.

Questions people often ask

Conditions where Colestyramine is being studied

Each condition opens its own overview and trial list

Trials with Colestyramine

Recruiting trials first

See all 4 →
Quick filters
  • Participants:Adults
  • Participants:Adults
  • Participants:Adults
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).